Eledon Pharmaceuticals Inc (ELDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 83,251 | 70,577 | 43,000 | 88,428 | 36,867 |
| Operating Income | -83,251 | -70,577 | -43,000 | -88,428 | -36,867 |
| Other Income | 37,669 | 34,824 | -73,537 | 462 | 7 |
| Pre-tax Income | -45,582 | -35,753 | -116,537 | -87,966 | -36,860 |
| Income Tax | 35 | 431 | N/A | N/A | -2,354 |
| Net Income Continuous | -45,617 | -36,184 | -116,537 | -87,966 | -34,506 |
| Net Income | $-45,617 | $-36,184 | $-116,537 | $-87,966 | $-34,506 |
| EPS Basic Total Ops | -0.52 | -0.66 | -3.74 | -6.16 | -2.33 |
| EPS Basic Continuous Ops | -0.56 | -0.75 | -4.73 | -6.16 | -2.33 |
| EPS Diluted Total Ops | -0.52 | -0.66 | -3.74 | -6.16 | -2.33 |
| EPS Diluted Continuous Ops | -0.56 | -0.75 | -4.73 | -6.16 | -2.33 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.01 | -1.64 | -2.75 | -2.33 |
| EBITDA(a) | $-83,251 | $-70,577 | $-42,626 | $-39,407 | $-36,672 |